HER2 Support Group Forums - View Single Post - Bevacizumab Improves Survival in Metastatic Breast Cancer

annettchen · 09-26-2014, 07:54 AM

Treatment with the combination of bevacizumab (Avastin) and chemotherapy improved progression-free survival (PFS) and overall survival (OS) in women with HER2-negative metastatic breast cancer, according to two phase III studies being presented at the 2014 ESMO Congress later this week.

http://www.onclive.com/conference-co...-Breast-Cancer

09-26-2014, 07:54 AM	#1
annettchen Senior Member Join Date: Mar 2014 Posts: 95	Bevacizumab Improves Survival in Metastatic Breast Cancer Treatment with the combination of bevacizumab (Avastin) and chemotherapy improved progression-free survival (PFS) and overall survival (OS) in women with HER2-negative metastatic breast cancer, according to two phase III studies being presented at the 2014 ESMO Congress later this week. http://www.onclive.com/conference-co...-Breast-Cancer __________________ Annette ---------------------------------------- 03/2014: Diagnosed with ER/PR-, HER2+++ MBC (bone mets, oligometastatic) 04/2014: Started 6 cycles of "PHD" (Perjeta, Herceptin, Docetaxol) 07/2014: Finished 6 cycles of PHD; restaging; 2 bone mets are sclerotic - looks like Herceptin and Perjeta is working 10/2014: STABLE! 01/2015: STABLE! 04/2015: STABLE! 08/2015: STABLE! 12/2015: BRAIN METS. BODY STABLE.